Publication | Closed Access

Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

Second-line ErlotinibTreatment Monitoring ProgramOncologyCancer ManagementPharmacotherapyCancer TreatmentMedicineRadiation OncologyLung Cancer